In 2023, the Supreme Court issued a decisive opinion that undermined the validity of broad functional genus claims for patents directed to biological antibodies. I published an article on IPWatchdog that examines numerous alternative strategies for patenting antibodies that can survive enablement and written description challenges, with a focus on paratope mapping with CDR-scanning technology. Go to IPWatchdog for full article.